SCILEX Pharmaceuticals, based in Malvern, PA, is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Committed to social, environmental, economic, and ethical principles, SCILEX aims to become a global leader in pain management, prioritizing the maximization of quality of life through responsible pharmaceutical product development.
With a diverse non-opioid pain management portfolio including ZTlido for post-herpetic neuralgia, Elyxyb for migraine treatment, and Gloperba for gout flare prophylaxis, SCILEX Pharmaceuticals is dedicated to providing effective solutions for pain relief while upholding stringent safety standards and regulatory compliance. Through a focus on innovation and strategic partnerships, SCILEX is positioned to make a significant impact in the pharmaceutical industry and improve patient outcomes worldwide.
Generated from the website